Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial

OBJECTIVE:To investigate the safety and efficacy of somatostatin as liver inflow modulator in patients with end-stage liver disease (ESLD) and clinically significant portal hypertension (CSPH) undergoing liver transplantation (LT) (ClinicalTrials.gov number,01290172). BACKGROUND:In LT, portal hyperp...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgery 2019-06, Vol.269 (6), p.1025-1033
Hauptverfasser:	Troisi, Roberto Ivan, Vanlander, Aude, Giglio, Mariano Cesare, Van Limmen, Jurgen, Scudeller, Luigia, Heyse, Bjorn, De Baerdemaeker, Luc, Croo, Alexander, Voet, Dirk, Praet, Marleen, Hoorens, Anne, Antoniali, Giulia, Codarin, Erika, Tell, Gianluca, Reynaert, Hendrik, Colle, Isabelle, Sainz-Barriga, Mauricio
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!